Codexis, Inc. (CDXS) Q1 2026 Earnings Call Transcript
Codexis (CDXS) Reports Q1 Loss, Beats Revenue Estimates
Codexis Reports First Quarter 2026 Financial Results
Codexis (CDXS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Codexis to share RNA manufacturing advances at TIDES USA
Codexis Posts Strong Q4, Eyes siRNA Market With ECO Synthesis Platform
Why Did Codexis (CDXS) Stock Soar Nearly 38% After Hours?
Codexis, Inc. (CDXS) Q4 2025 Earnings Call Transcript
Codexis (CDXS) Beats Q4 Earnings and Revenue Estimates
Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results
Codexis Targets 2026 Inflection as CEO Touts ECO Synthesis Push in RNA Manufacturing at TD Cowen Conf
Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis® Manufacturing Platform
Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11
Codexis Achieves ISO 9001:2015 Certification
Codexis, Inc. $CDXS Shares Sold by Federated Hermes Inc.
Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics
Down 30% in 4 Weeks, Here's Why You Should You Buy the Dip in Codexis (CDXS)
Codexis Announces Signing of Lease for GMP Manufacturing Facility
Codexis, Inc. (CDXS) Q3 2025 Earnings Call Transcript
Codexis (CDXS) Reports Q3 Loss, Misses Revenue Estimates
Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing
Codexis to Report Third Quarter 2025 Financial Results on November 6
Codexis to Participate in Cantor Global Healthcare Conference
Codexis, Inc. (CDXS) Q2 2025 Earnings Call Transcript
Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates
Codexis Reports Second Quarter 2025 Financial Results
Codexis to Report Second Quarter 2025 Financial Results on August 13
Codexis' Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA
Codexis to Participate in Jefferies Global Healthcare Conference
Codexis, Inc. (CDXS) Q1 2025 Earnings Call Transcript
Codexis (CDXS) Reports Q1 Loss, Misses Revenue Estimates
Codexis Reports First Quarter 2025 Financial Results
Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting
Codexis to Report First Quarter 2025 Financial Results on May 14
Codexis (CDXS) Expected to Beat Earnings Estimates: Should You Buy?
Codexis Announces Byron Dorgan to Retire from Board of Directors
Codexis Announces New Employment Inducement Grants
Codexis, Inc. (CDXS) Q4 2024 Earnings Call Transcript
Codexis (CDXS) Reports Q4 Loss, Misses Revenue Estimates
Codexis Announces New Employment Inducement Grants
Codexis to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 27th
Codexis Appoints Arthur Levin, PhD, to Strategic Advisory Board
Codexis Appoints Christos Richards to Board of Directors
Codexis Announces New Employment Inducement Grants
Codexis Announces New Employment Inducement Grants
Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference
Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics
Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors
Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics
Codexis Announces New Employment Inducement Grants